(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | 12.70%1.76B | 11.32%831.16M | 15.13%1.56B | 15.23%746.62M | 24.05%1.36B | --647.96M | 3.24%1.09B | 24.02%1.06B | --853.76M |
Operating income | 12.70%1.76B | 11.32%831.16M | 15.13%1.56B | 15.23%746.62M | 24.05%1.36B | 647.96M | 3.24%1.09B | 24.02%1.06B | 853.76M |
Cost of sales | -7.63%-1.1B | -4.96%-521.51M | -14.23%-1.02B | -16.11%-496.84M | -25.99%-895.92M | ---427.91M | -0.30%-711.11M | -19.67%-708.97M | ---592.42M |
Operating expenses | -7.63%-1.1B | -4.96%-521.51M | -14.23%-1.02B | -16.11%-496.84M | -25.99%-895.92M | -427.91M | -0.30%-711.11M | -19.67%-708.97M | -592.42M |
Gross profit | 22.36%658.13M | 23.97%309.65M | 16.89%537.87M | 13.51%249.78M | 20.44%460.16M | 220.05M | 9.20%382.05M | 33.88%349.88M | 261.34M |
Selling expenses | -47.63%-103.17M | -21.71%-44.53M | 8.33%-69.89M | 3.83%-36.59M | -13.61%-76.24M | ---38.04M | 10.89%-67.1M | -19.78%-75.31M | ---62.87M |
Administrative expenses | -13.02%-174.99M | -16.91%-73.19M | -6.21%-154.83M | 2.71%-62.61M | -29.82%-145.78M | ---64.35M | -4.04%-112.29M | -9.33%-107.93M | ---98.72M |
Impairment and provision | -98.07%-14.39M | -865.01%-30.95M | -54.50%-7.26M | 11.24%-3.21M | -214.45%-4.7M | ---3.61M | -156.31%-1.5M | 119.85%2.66M | ---13.38M |
-Other impairment is provision | -98.07%-14.39M | -865.01%-30.95M | -54.50%-7.26M | 11.24%-3.21M | -214.45%-4.7M | ---3.61M | -156.31%-1.5M | 119.85%2.66M | ---13.38M |
Operating interest expense | ---- | 49.31%-7.46M | ---- | 15.82%-14.71M | 25.75%-34.95M | ---17.47M | 0.78%-47.08M | -402.19%-47.45M | ---9.45M |
Special items of operating profit | 3,395.93%41.25M | 1,828.54%34.64M | -93.26%1.18M | -129.67%-2M | 1,338.90%17.5M | --6.76M | -93.10%1.22M | 9.89%17.62M | --16.03M |
Operating profit | 32.49%406.84M | 44.00%188.17M | 42.17%307.07M | 26.46%130.67M | 39.08%215.99M | 103.33M | 11.36%155.31M | 50.03%139.47M | 92.96M |
Financing cost | 46.98%-13.65M | ---- | ---25.74M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -153.16%-126K | -77.50%36K | 134.00%237K | 121.59%160K | ---697K | ---741K | ---- | ---- | ---- |
Share of profit from joint venture company | -66.67%-50K | -66.67%-50K | 84.38%-30K | 62.50%-30K | -357.14%-192K | ---80K | 72.37%-42K | ---152K | ---- |
Earning before tax | 39.59%393.01M | 43.85%188.15M | 30.89%281.54M | 27.60%130.8M | 38.54%215.1M | 102.51M | 11.45%155.26M | 49.86%139.32M | 92.96M |
Tax | -100.13%-65.99M | -132.99%-29.58M | -4.41%-32.97M | 32.80%-12.7M | -17.83%-31.58M | ---18.89M | 2.24%-26.8M | -89.08%-27.42M | ---14.5M |
After-tax profit from continuing operations | 31.56%327.02M | 34.27%158.58M | 35.44%248.57M | 41.24%118.1M | 42.86%183.52M | 83.62M | 14.80%128.46M | 42.62%111.9M | 78.46M |
Earning after tax | 31.56%327.02M | 34.27%158.58M | 35.44%248.57M | 41.24%118.1M | 42.86%183.52M | 83.62M | 14.80%128.46M | 42.62%111.9M | 78.46M |
Profit attributable to shareholders | 31.56%327.02M | 34.27%158.58M | 35.44%248.57M | 41.24%118.1M | 42.86%183.52M | 83.62M | 14.80%128.46M | 42.62%111.9M | 78.46M |
Basic earnings per share | 32.76%0.77 | 32.14%0.37 | -1.69%0.58 | 3.70%0.28 | 40.48%0.59 | 0.27 | 0.42 | ||
Diluted earnings per share | 32.76%0.77 | 32.14%0.37 | -1.69%0.58 | 3.70%0.28 | 40.48%0.59 | 0.27 | 0.42 | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data